Immunohistochemical Expression of P53and Oncogenes in Ulcerative Colitis-associated ColorectalCarcinoma

No abstract is available for this paper.

• Publication year

  2002

• Venue

  World Journal of Surgery

• Publication date

  2002-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00268-001-0237-7PMID 11865380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 immunohistochemistry of ulcerative colitis‐associated with dysplasia and carcinoma

  1999cited by this paper
• Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis

  1999cited by this paper
• Molecular screening of patients with long standing extensive ulcerative colitis: detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonic lavage fluid

  1999cited by this paper
• Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.

  1999cited by this paper
• Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas

  1999cited by this paper
• Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis

  1999cited by this paper
• [Malignant transformation in ulcerative colitis and surgical implications].

  1998cited by this paper
• Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma.

  1998cited by this paper
• Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.

  1998cited by this paper
• Expression of cyclin‐dependent kinase inhibitor p21 in human liver

  1998cited by this paper
• Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue.

  1997cited by this paper
• Recent Advances in Molecular Genetics of Colorectal Cancer

  1997cited by this paper
• Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer.

  1997cited by this paper
• The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis

  1996cited by this paper
• Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas.

  1996cited by this paper
• p21/WAF1/CIP1 EXPRESSION IN NORMAL MUCOSA AND IN ADENOMAS AND ADENOCARCINOMAS OF THE COLON: ITS RELATIONSHIP WITH DIFFERENTIATION

  1996cited by this paper
• P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis.

  1996cited by this paper
• Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia.

  1996cited by this paper
• p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.

  1996cited by this paper
• Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia

  1996cited by this paper
• Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis.

  1995cited by this paper
• Molecular genetics of dysplasia in ulcerative colitis.

  1995cited by this paper
• Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis.

  1995cited by this paper
• bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.

  1995cited by this paper
• Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.

  1994cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma.

  1994cited by this paper
• An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

  1994cited by this paper
• Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry

  1994cited by this paper
• Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis.

  1994cited by this paper
• Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

  1994cited by this paper
• c-src tyrosine kinase activity: a marker of dysplasia in ulcerative colitis.

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• p53 point mutations in dysplastic and cancerous ulcerative colitis lesions.

  1993cited by this paper
• Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele.

  1992cited by this paper
• Amplification of a gene encoding a p53-associated protein in human sarcomas

  1992cited by this paper
• Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.

  1992cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53‐mediated growth arrest.

  1992cited by this paper
• Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

  1992cited by this paper
• Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval.

  1991cited by this paper
• Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper
• p53 mutations in colorectal cancer.

  1990cited by this paper
• Ulcerative colitis and colorectal cancer. A population-based study.

  1990cited by this paper
• Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome.

  1989cited by this paper
• Cancer in universal and left-sided ulcerative colitis: factors determining risk.

  1979cited by this paper

• Genetic Analysis of Biopsy Tissues from Colorectal Tumors in Patients with Ulcerative Colitis

  2024cites this paper
• STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis

  2019cites this paper
• p53 expression in patients with ulcerative colitis - associated with dysplasia and carcinoma: a systematic meta-analysis

  2017cites this paper
• Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia

  2016cites this paper
• Lower Gastrointestinal Tract

  2015cites this paper
• The expression of apoptosis-related proteins in patients with ulcerative colitis

  2014cites this paper
• Chronisch-entzündliche Erkrankungen des Kolorektums

  2013cites this paper
• Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.

  2013cites this paper
• Colitis ulcerosa, imagen de banda estrecha e inmunoexpresión p53

  2013cites this paper
• Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease‐associated colorectal cancer

  2012cites this paper
• Chapter 14 – Immunohistology of the Gastrointestinal Tract

  2011cites this paper
• IBD-related carcinoma and lymphoma.

  2011cites this paper
• Lower Gastrointestinal Tract and Microsatellite Instability

  2011cites this paper
• WNT-Pathway Activation in IBD-Associated Colorectal Carcinogenesis: Potential Biomarkers for Colonic Surveillance

  2010cites this paper
• Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.

  2009cites this paper
• Inducible heat shock protein 70 prevents multifocal flat dysplastic lesions and invasive tumors in an inflammatory model of colon cancer.

  2009cites this paper
• A case of lymphoepithelioma-like carcinoma of the colon with ulcerative colitis

  2007cites this paper
• Molecular profiling of ulcerative colitis-associated neoplastic progression.

  2006cites this paper
• Cancer surveillance in inflammatory bowel disease: new molecular approaches

  2006cites this paper
• Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.

  2003cites this paper
• Is Colonoscopy Alone Sufficient to Screen for Ulcerative Colitis-associated Colorectal Carcinoma?

  2003cites this paper
• Metallothionein: Early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma

  2002cites this paper